Who to call at GoodRx Holdings, Inc., and when
Fundz watches for the moments GoodRx Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day GoodRx Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GoodRx Holdings, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GoodRx Holdings, Inc.. With Fundz connected, it knows.
GoodRx Holdings, Inc.
The company said earlier financial statements can no longer be relied on. An 8-K is the notice a US public company must file within four business days of a major event.
www.goodrx.comExecutive Summary
Analysis of 8-K filing content
GoodRx Holdings announced on October 27, 2026 that its Audit and Risk Committee concluded previously issued financial statements for Q1 and Q2 2026 should no longer be relied upon due to understatement of Pharma Direct revenue. The company will restate financials, increasing reported revenue by $29.8M and net income by $14.8M for the six-month period.
Key Takeaways
Pharma Direct revenue was understated by $7.5M in Q1 2026 and $22.3M in Q2 2026 due to improper revenue recognition under ASC 606
Restatement increases six-month net income from $9.7M to $24.6M and diluted EPS from $0.03 to $0.07
3 more takeaways
Related Filings (1)
1 more filing from GoodRx Holdings, Inc. in the last 90 days
Filing Overview
What This Means
GoodRx Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.